Former buy-side analyst. Leads the desk with a focus on global markets, macro flows and what moves portfolios.

Asian stocks edged higher as oil held near a three-week low, with traders still pricing a September Fed rate hike. Here's what it means for

Theon posted strong quarterly results, with revenue up 35% and operating margins at 26%. Now, planned acquisitions could expand its reach be

AI infrastructure stocks have been hit hard by a wave of fear, but the underlying business fundamentals remain strong. Here's what's driving

Qantas is exiting Jetstar Japan, selling its 33.32% stake through an 8.2 billion yen share buyback with Japan Airlines. The deal, pending re

Danaher has chosen Julie Sawyer Montgomery, a longtime executive, to become its next CEO on October 1, succeeding Rainer Blair, who is retir

The majority owner of SuKarne, one of Mexico's largest meat exporters, is reportedly weighing a sale that could value the company at more th

New municipal bond deals are being tagged with climate risk scores, with some hitting 5.0 on ICE's scale. This shift could reshape how inves

Visa is paying $2.4 billion in cash for BioCatch, a fraud intelligence firm. The deal comes as 10-year Treasury yields slipped to 4.69%, hel

Movie theater stocks popped on record box office results, while Marriott slid after a soft quarter. The split shows why 'the consumer' isn't

Gold slipped to near $4,037 an ounce as traders weighed oil-driven inflation worries against a packed week of US jobs data. The data could s

S&P 500 earnings are still growing fast, but the pace is cooling. Tech's explosive jump is fading, while energy and consumer discretionary s

RBC Capital Markets says AbbVie's blockbuster drugs Skyrizi and Rinvoq are holding up well, but pricing pressure will persist. The next big